Tradestie Institutional Equity Comparison Engine
ARVN vs MRVI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ARVN Overall Edge
ARVN Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arvinas, Inc (ARVN) driven by superior Valuation, Growth & Margin while MRVI counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ARVN trades at 17.9x Forward P/E with -10.1% operating margin (-98.8% YoY revenue) versus MRVI at N/M Forward P/E and -24.2% operating margin (+10.1% YoY). In options structure, ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against MRVI sits in BREAKOUT (17th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ARVN
ARVN 17.9x vs MRVI N/M Fwd P/E
Growth & Margin Winner
ARVN
Op Margin -10.1% vs -24.2% ยท YoY -98.8% vs +10.1%
Momentum & Technical Winner
MRVI
1Y -33.4% vs +129.2% ยท 52W Pos 5% vs 70%
Options & Structure Winner
MRVI
BREAKDOWN (25th %ile IV) vs BREAKOUT (17th %ile IV)
ARVN
NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap
$449.9M
1M Return
-3.3%
1Y Return
-33.4%
Forward P/E
17.9x
Unified AI Score
52.9 / 100
HOLD
Tech 54.0
Fund 59.0
Flow 71.0
Mom 54.0
MRVI
NASDAQ
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Pharmaceutical Preparations
$7.45
-1.19% 1D
Market Cap
$2.0B
1M Return
+9.72%
1Y Return
+129.23%
Forward P/E
N/M
Unified AI Score
49.0 / 100
HOLD
Tech 37.0
Fund 48.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARVN -33.4%
MRVI +129.23%
Spread: +162.63 pp (MRVI Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ARVN Revenue | MRVI Revenue | ARVN Op. Margin | MRVI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | N/A | -306.3% | N/A | ARVN |
| FY2019 | $20M | $140M | -281.4% | 16.8% | MRVI |
| FY2020 | $20M | $280M | -554.1% | 42.2% | MRVI |
| FY2021 | $50M | $800M | -403.4% | 69.4% | MRVI |
| FY2022 | $130M | $880M | -200.3% | 65.0% | MRVI |
| FY2023 | $80M | $290M | -511.5% | -11.0% | MRVI |
| FY2024 | $260M | $260M | -95.0% | -90.9% | MRVI |
| FY2025 | $260M | $190M | -45.1% | -115.9% | ARVN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARVN | MRVI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $449.9M | $2.0B | Larger Scale | MRVI |
| Trailing P/E Ratio Valuation | 17.9x | N/M | Lower Multiple | ARVN |
| Forward P/E Ratio Valuation | 17.9x | N/M | Lower Multiple | ARVN |
| Revenue Growth (YoY) Growth | -98.8% | +10.1% | Higher Growth | MRVI |
| Operating Margin (TTM) Profitability | -10.1% | -24.2% | Higher Margin | ARVN |
| Net Profit Margin Profitability | -3.5% | -30.8% | Higher Margin | ARVN |
| Return on Equity (ROE) Capital Efficiency | -1.8% | -29.8% | Higher ROE | ARVN |
| 52-Week Range Position Momentum | 5% ($6โ$15) | 70% ($3โ$9) | Stronger Trend | MRVI |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 66% Vol | 1.61ฮฒ ยท 83% Vol | Lower Realized Risk | ARVN |
| Unified Institutional Score Composite Signal | 52.9 / 100 (HOLD) | 49.0 / 100 (HOLD) | Higher Composite | ARVN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARVN vs MRVI Buy Guide
ARVN
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
MRVI
BREAKOUT
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARVN nor MRVI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.